Nanodevices have emerged as transformative tools in the field of pharmaceuticals, offering unprecedented opportunities for precision medicine and targeted drug delivery. These miniature devices, typically on the nanometer scale, enable the manipulation and control of biological processes at the molecular level. In the pharmaceutical realm, nanodevices play a pivotal role in enhancing drug efficacy while minimizing side effects. By exploiting their unique properties, such as high surface area and reactivity, nanodevices can be designed to encapsulate, transport, and release therapeutic agents with remarkable precision.
This level of control is particularly crucial in addressing challenges like drug solubility and bioavailability. Furthermore, nanodevices offer the potential for real-time monitoring and diagnostics, facilitating a more personalized approach to patient care. The development of nanodevices in pharmaceuticals represents a promising frontier, promising to revolutionize drug delivery systems and significantly improve the therapeutic outcomes for various medical conditions. As research in nanotechnology continues to advance, the integration of nanodevices in the pharmaceutical field holds great promise for the development of innovative and highly effective therapeutic solutions.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico